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Foreword
As the following pages make clear, the Aga Khan University is
conducting cutting-edge research in settings ranging from the
laboratory to rural areas, and delivering important findings that
can improve people’s lives in Asia, Africa and beyond.

Sulaiman Shahabuddin
President and Chief
Executive Officer

Our faculty members are using artificial intelligence to identify at-risk
newborns in low-income communities. They are working to develop a
stem cell-based therapy for a form of leukaemia. With a US$ 6.5 million
grant from the US National Institutes of Health, they are employing
machine learning to predict a woman’s risk of experiencing pregnancy
complications. AKU researchers have produced actionable insights
into science and mathematics education in public and private schools,
examined the impact of technological and political shifts on the news media
in East Africa and revealed how a new generation of Muslim musicians
is reimagining the relationship between Islam and popular music.

Carl Amrhein
Provost and Vice
President, Academic

Anjum Halai
Vice Provost, Asia and UK and
Dean, Faculty of Arts and Sciences

As the pandemic has wreaked havoc across the globe, AKU has helped to
enhance scientists’ understanding of the novel coronavirus and to equip
the world with new tools in the fight against it. In Pakistan and Kenya,
the University has participated in international clinical trials of COVID-19
vaccines, treatments and diagnostics, several of which are now in use
around the world. AKU contributed to an 18-country study that was among
the first to reveal the danger that COVID-19 poses to pregnant women and
their babies. Meanwhile, our scientists are elucidating the role that different
genes play in fighting SARS-CoV-2, and they are at the forefront of efforts
to track the evolution and spread of new variants of the virus in Pakistan.
With each passing year, AKU’s research capacity continues to grow.
Faculty published almost 1,300 studies in peer-reviewed journals in
2020, an all-time high and a 72 percent increase compared to 2015. The
University attracted more than US$ 32 million in research grants in 2020,
exceeding the figure for every recent prior year save 2016. With several
months still left in 2021, we have already received more research funding
than in 2020, and our publications output may set another record. There
is every reason to believe that AKU research will continue to deliver
solutions to pressing problems, to advance knowledge in an increasingly
wide array of fields and to demonstrate the vital role that low- and middleincome countries can play in the global process of scientific inquiry.

Fauziah Rabbani
Professor and Associate
Vice Provost, Research

Alex Awiti
Vice Provost, East Africa
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In AI, researchers see
a tool for identifying
at-risk newborns
An algorithm could identify babies with
infections and congenital heart disease

AKU RESEARCH

An AKU research team has a vision:
to prevent newborn babies in lowincome communities from dying
by equipping community health
workers with an artificial-intelligence
algorithm that can detect lifethreatening conditions early, enabling
timely referral and management.

Sociodemographic,
clinical and pulse
oximetry data will be
obtained from 1,000
newborns in a periurban area of Karachi.

“Can artificial intelligence help Pakistan
and other countries with limited
health care resources to triage atrisk newborns and ensure they get
the care they need?” asked Assistant
Professor Zahra Hoodbhoy, the project’s
principal investigator. “That’s the big
question we’re trying to answer.”
The first step for Dr Hoodbhoy and her
colleagues is to develop an algorithm
that can identify newborns suffering
from infections and congenital heart
disease by analyzing pulse oximeter

readings and waveforms, along with
clinical and sociodemographic data.
A pulse oximeter is a widely used,
relatively inexpensive device that
clips onto the finger and measures
pulse rate and blood oxygen levels.
Pulse oximeters can also generate
waveforms, which are visual
representations of blood flow.
Approximately 2.4 million children die
in their first month of life every year.
Infections and congenital defects
such as congenital heart disease
are among the leading causes of
newborn deaths. Preventing deaths
from such conditions depends on
early detection, but early detection is
difficult in areas where highly trained
physicians and expensive diagnostic
devices are scarce. Hence the need
for innovative, affordable methods for
screening large numbers of newborns.

The data researchers need to develop
their algorithm will be obtained from
1,000 newborns in Ibrahim Hyderi,
a peri-urban area of Karachi. The
University’s Department of Paediatrics
and Child Health has long been working
in Ibrahim Hyderi to improve maternal
and child health and has earned
the community’s trust. So far, the
project has enrolled 850 newborns.
Dr Hoodbhoy’s co-investigator at
AKU is Associate Professor Babar
Hasan. The University’s collaborators
on the project are Cardiology Care
for Children in the United States and
the University of Barcelona’s August
Pi i Sunyer Biomedical Research
Institute. Funding has been provided
by the Islamic Development Bank.
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Big data + machine
learning = better
health in East Africa?
A major NIH grant kickstarts a
new era in data science at AKU

The largest data-science research
initiative in AKU’s history is now
underway. Backed by a US$ 6.5 million
grant from the US National Institutes
of Health, researchers at AKU and its
partner institutions will seek to identify
individuals at risk of future health
problems using machine-learning and
other artificial intelligence techniques.
The project is a collaboration among
AKU, the University of Michigan and
the Kenya Medical Research Institute/
Wellcome Trust Research Programme
(KEMRI/WTRP). It is part of a broader
push by AKU to become a leader in
the use of data science to improve
health in the developing world.
“Our goal is to develop tools that
enable the early identification and early
treatment of health problems,” said
8

Professor Amina Abubakar, Director of
AKU’s Institute for Human Development.
“To do that, we’ll try to identify hidden
patterns in mountains of data, so that
eventually we can say ‘this person has
characteristics a, b and c, and therefore
they are likely to develop disease x.’”
Machine learning is used to develop
software that can perform complex
tasks – for example, recognizing
when a photograph depicts one
type of object rather than another.
Programmers could try to do that by
writing parameters that specify exactly
how to recognize a bus, truck, train, etc.
– but it would be extremely laborious.
With machine learning, one instead
writes a programme and feeds it data
(for example, millions of photographs)
that allows it to learn for itself how to
distinguish among different objects.

The AKU project consists of
two initiatives, one focused on
maternal and child health and
one focused on mental health.

adverse events. They will also try to
predict how children under the age of
6 will fare later in life – academically,
economically and in other ways.

In the maternal and child health
component, researchers will work to
predict a woman’s risk of experiencing
pregnancy complications, delivering
an underweight baby, developing
cardiovascular problems and other

To develop their models, researchers
will utilize data from a number of
longitudinal health studies in Kenya
that have collected information
on more than 400,000 people.

Prediction models
will be developed
using health data on
400,000 Kenyans
collected by AKU and
its partners.

KEMRI/WTRP has collected data on
300,000 children, adults and pregnant
women in Kenya’s Kilifi County through
three studies. AKU has collected data
on 90,000 households in Kilifi, and is
also participating in a study that aims
to recruit 4,000 pregnant women,
including hundreds from Kilifi. Data
on 10,000 pregnant women will be
provided by the Aga Khan University
Hospital, Nairobi, as well as the

Aga Khan Hospital, Mombasa and
the Aga Khan Hospital, Kisumu.
In the project’s mental health
component, researchers will seek to
identify predictors of mental health
disorders. They will do so in three
ways. First, they will collect data
from health workers at the Aga Khan
University Hospital, Nairobi and the
Nairobi Hospital using a fitness tracker
and a mobile app developed by the
University of Michigan. The app
has previously been used to predict
the short-term risk of depressive
episodes among interns in hospitals
in the United States and China.
Second, they will develop prediction
models using sociodemographic,
health and behavioural data on 9,000
young people (ages 8-24) in Kilifi
collected by KEMRI/WTRP. Third, they

will recruit 5,000 Kenyan university
students for a study. The students will
complete detailed surveys at regular
intervals, furnishing researchers with
mental health and other data.
A developmental psychologist,
Professor Abubakar is the Director of
the project, which is known as Utilizing
Health Information for Meaningful
impact in East Africa though Data
Science (UZIMA-DS). Professor
Akbar Waljee of the University of
Michigan is the project’s Co-Director.
A gastroenterologist who leads the
Michigan Integrated Center for Health
Analytics and Medical Prediction, his
past research focuses on the use of
machine learning in healthcare.
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Developing novel
therapies for leukaemia
and blood disorders
Gene therapy and stem cell therapy could
deliver effective, affordable treatments
Researchers at AKU’s Centre for
Regenerative Medicine and Stem Cell
Research (CRM) are working to develop
new treatments for two inherited
blood disorders – beta thalassemia
and sickle cell anaemia – as well as
a form of blood cancer, Philadelphia
chromosome-positive leukaemia. Their
work is being funded by US$ 1 million
from Pakistan’s Higher Education
Commission and the World Bank.
Both beta thalassemia and sickle
cell anaemia are the result of genetic
mutations that cause their victims to
suffer from a lack of haemoglobin,
limiting the flow of oxygen through the
body. Symptoms include fatigue and
weakness, and – in the case of sickle
cell anaemia – episodes of severe
pain. The disorders can also have
severe complications, including stroke,
blindness and heart failure. Pakistan is
thought to have a high incidence of beta
thalassemia and sickle cell anaemia due
to the prevalence of consanguineous
marriage (marriages between
descendants of a shared ancestor).
Treatments for the disorders include
blood transfusions and bone marrow
transplants, but both have drawbacks
and side effects. Blood transfusion
often leads to iron overload and organ
damage, while bone marrow transplant
10

is a costly, risky and invasive treatment
available only to patients who can find
suitable donors. Pakistan also lacks
bone marrow transplant facilities and
expertise, which means that most
patients cannot obtain transplants.
Assistant Professor Afsar Mian and
his colleagues aim to use CRISPR/
Cas9, a gene-editing tool, to
develop a drug that would repair the
genetic defect responsible for beta
thalassemia and sickle cell anaemia.
“Our goal is to deliver an innovative,
less-invasive and more affordable
cure for these common genetic
diseases,” Professor Mian said.
Researchers will also attempt to
increase the production of foetal
haemoglobin in individuals with beta
thalassemia and sickle cell anaemia.
Adults carry small amounts of foetal
haemoglobin, and higher levels are
associated with milder disease in
individuals with beta thalassemia
and sickle cell anaemia. Increasing
levels would involve using CRISPR/
Cas9 to suppress the gene that limits
foetal haemoglobin production.
The chromosomal defect known as
Philadelphia chromosome (Ph) leads
to certain blood cells becoming

cancerous. It is characteristic of
two types of blood cancer: chronic
myeloid leukaemia and Ph-positive
acute lymphoblastic leukaemia.
While medications for these diseases
exist, survival rates remain poor in
patients with advanced stages of the
disease due to drug resistance and
side effects. CRM researchers are
looking to develop a more effective
treatment by engineering stem cells
to deliver a peptide with therapeutic
properties (the Helix 2 peptide)
directly to leukaemia cells. Among
other benefits, this treatment would
only need to be administered once.
(A peptide is similar to a protein
but contains fewer amino acids.)
“We are anticipating that once
introduced, the stem cells will
grow and multiply in the body and
continuously release the therapeutic
peptide to target the cancer cells,
inhibit their growth and ultimately cure
the disease,” said Professor Mian,
the study’s principal investigator.
Researchers hope their work will
generate evidence that advances efforts
to use peptides to treat other cancers.

Researchers aim
to develop a genetherapy drug using
CRISPR/Cas9, a
gene-editing tool.
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“We are going to
enjoy ourselves,
in a halal way!”
ISMC professor examines
the faith-driven pop of the
record label Awakening

In his new book, The Awakening of
Islamic Pop Music, Professor Jonas
Otterbeck examines the international
media company Awakening, which
has sold more than 5 million albums
by artists such as Sami Yusuf, Maher
Zain and Hamza Namira, helping
to give birth to the music dubbed
Islamic pop or pop-nashid. Along the
way, Otterbeck, of AKU’s Institute for
the Study of Muslim Civilisations in
London, provides a genealogy of the
genre and a brief history of Islamic
discourses on popular music, from
the ninth century to the present.

an American-Lebanese engineer, and
British-Pakistani Wali-ur Rahman.
Kherigi and Banna are particularly
well-versed in Islam – the former has
a BA in Islamic jurisprudence from
Al-Azhar University in Cairo, while the
latter is working towards a PhD in the
same subject at Al-Azhar. Otterbeck
met Banna, Awakening’s CEO, at a
conference in 2008, and his book is
based on extensive conversations
with him, his co-founders and the
label’s musicians, as well as media
analysis and fieldwork that includes
joining Awakening’s artists on tour.

Awakening was founded in London in
2000 by four friends in their twenties.
Sharif Banna and Bara Kherigi knew
each other from their time at the School
of Oriental and African Studies (SOAS).
Their co-founders were Wassim Malak,

Awakening’s trademark is glossily
produced, “faith-driven” pop. Sex,
drugs and hedonism, as well as dancing
of any kind, are out. Praise for Allah
and a general air of uplift are in. Within
their self-imposed limits, Awakening
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musicians are magpies, drawing on
Arab and Turkish pop, R&B, rock,
reggae, qawwali and whatever else
comes to hand. A single artist might
deploy English, Arabic, Urdu and Turkish
– mixing multiple languages in one
song or recording multiple versions of a
track for different markets. Awakening
singers might also record a “vocals
only” song for believers who reject the
use of instruments as un-Islamic, while
also recording the same song with a full
band. Indeed, as Otterbeck extensively
documents, the company has helped
normalize the use of instruments among
more traditional Muslim audiences.
In the company’s own words,
“Awakening’s intention was not to
reform Islam, but to contemporise it.
They recognised there was a collective
Muslim identity crisis, and they sought

to reconcile the false notion that
Islam is at odds with modernity by
offering an equally modern service
within Islamic parameters … The
messages in the Awakening songs
of hope, self-improvement and
serving the community resonate
with their audiences who identify
with this vision. It is aspirational.”
Handsome, mild-mannered, welldressed, clean-living and apt
to discourage female audience
members from fawning over them,
the typical Awakening singer is in his
element at a charity event or Islamic
conference – whether in London, Cairo,
Istanbul, Jakarta or Kuala Lumpur.
Revving up an audience, he might
cry, as Otterbeck reports Maher Zain
once did, “Let that energy loose, we

are going to enjoy ourselves, in a
halal way!” If he is not usually overtly
political, in certain circumstances he
may offer a good word for, say, Turkish
President Recep Tayyip Erdogan or an
Indonesian presidential candidate.
Awakening is not without its critics.
Sami Yusuf – the company’s first
star, who left the label in 2008 – has
accused it of becoming, in Otterbeck’s

Awakening artists such
as Maher Zain draw on
Arab and Turkish
pop, R&B, rock, reggae,
qawwali and whatever
else comes to hand.

formulation, “just a ruthless, commercial
company that has lost track of Islam.”
Yet such criticisms are unlikely to carry
much weight with the millions of fans for
whom Awakening has succeeded in its
ambition “to provide modern Muslims
with appealing soundtracks to their
lives.” In closing his book, Otterbeck
writes that “the Awakening founders
are now in their forties and they have
orchestrated their personal, and perhaps
their generation’s, understanding of
music and entrepreneurship for the
masses. Young adults in particular
have paid attention and listened,
and among the youth of today are
tomorrow’s scholars and artists.”
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East Africa’s news
media strive to
meet threats to
freedom, profits
GSMC assesses the future of news
in Kenya, Tanzania and Uganda

The future of East Africa’s news media
is clouded by government efforts to
limit press freedom, the internet’s toll on
industry revenues and shifting audience
preferences, according to a trio of
studies undertaken by AKU’s Graduate
School of Media and Communications
in Nairobi. Yet as more and more East
Africans gain access to the internet, there
are opportunities for established media
organizations to reinvent themselves
and for newcomers to capture
audiences with high-quality reporting.
The Media Viability in East Africa studies
cover Kenya, Uganda and Tanzania.
They were undertaken as part of Media
Futures East Africa, a joint project with
DW Akademie, the capacity-building
arm of German broadcaster Deutsche
Welle. Each 40-page report is based
on a review of existing literature and
represents the work of nine authors.
Although Kenya’s 2010 constitution
guarantees freedom of expression

and of the media, the freedom and
independence of the media is under
threat. In recent years, the government
has stepped up efforts to force journalists
to toe the official line. For example, a
new law allows for imprisonment and
steep fines for anyone who intentionally
publishes “misleading” information.
Media ownership mitigates against
unbiased reporting, as a number
of major companies are owned by
or affiliated with powerful political
figures. Large advertisers are known
to pressure media managers to deliver

The finances of
news companies
are deteriorating as
advertisers flock to
Google, Facebook and
other online outlets.

favourable coverage of their political
allies. Journalists have been fired by
their employers for coverage critical of
the government and self-censorship by
reporters and editors is widespread.
At the same time that the government
has exerted increasing pressure, the
finances of many news companies
are deteriorating. Advertisers have
flocked to Google, Facebook and other
destinations online. Audiences have
shifted from purchasing newspapers
to reading them online for free. The
government, once a crucial source of
advertising revenues, has cut back on
its expenditures. In response, media
organizations have been forced to
lay off large numbers of journalists.
Yet Kenya’s media organizations are not
taking these changes lying down. Many
reporters remain feisty and committed
to serving the public interest. The
public is keenly interested in news and
politics. Pre-pandemic, the advertising
market was projected to grow rapidly.
15

And while the internet has wreaked
financial havoc, the growth in the number
of people who have smartphones
or who occasionally access the
internet (around 40 percent of adults,
according to the Washington-based
Pew Research Center) is opening up
new opportunities for journalists. In a
major shift, some media houses have
started charging for their coverage
online, having long suffered from what
one industry veteran called “the original
sin” of giving content away for free.
GSMC Research Associate Hesbon
Hansen Owilla, one of the authors of
the studies, says it seems Kenya’s
media sector has finally achieved some
clarity regarding the way forward.
“People tried entertainment and gossip,
they tried giving away content for free,”
he said. “They’ve realized they need
to charge, and in order to do that, you
have to offer people something that is
unique, that is high quality. I think that

after years of declining quality, we’re
going to see better, more incisive, more
in-depth, more authoritative content.”
In Uganda, the media faces many of
the same challenges as in Kenya. The
government has exerted its authority
by shutting down the internet during
elections, arresting journalists, taxing
internet data and requiring media
organizations to seek government
approval to operate. While fewer people
have access to the internet than in
Kenya, its impact on revenues is being
felt by an industry that already faced
the challenge of attracting advertising
spending in a country with a per
capita GDP of around $800, roughly
half that of Kenya’s. With salaries low,
journalists are known to be susceptible
to bribery. In short, news organizations
“are likely to face increased obstacles
in producing high-quality journalism.”
Similarly, in Tanzania, former President
John Magufuli’s six years in office were

characterized by bans, suspensions,
fines and arrests directed against
news organizations and journalists
deemed critical of the government.
As in Kenya and Uganda, news
organizations in Tanzania are competing
for a limited pool of advertising
spending, and the government has
looked to use its own advertising budget
to influence journalists’ coverage.
Tanzanian journalists also face a more
skeptical public than their northern
colleagues: a majority of citizens
believe the government should be able
to prevent publication of information
it considers harmful to society.
Nonetheless, there are signs of internetenabled innovation in Tanzania as
elsewhere in the region. For example,
users of JamiiForums, a social network
that has been targeted by authorities,
have repeatedly exposed corruption,
earning founder Maxence Melo an
International Press Freedom award.
17
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The average math
score was 27 out of
100. The average
science score was
34 out of 100.

Nationwide study
reveals limited
learning in math
and science
Researchers examined the factors
influencing scores for 15,000
students in Pakistan

More than 90 percent of primary and
lower-secondary students in Pakistan
have only a weak or basic understanding
of the mathematics and science they
are required to learn, according to a
nationwide study conducted by faculty
at AKU’s Institute for Educational
Development, Pakistan (IED).
More than 15,000 students in grades
five, six and eight in 153 public and
private schools across the country
completed standardized tests in
mathematics and science as part of the
study, which was funded by Pakistan’s
Higher Education Commission. All tests
were aligned with Pakistan’s curriculum
and have been validated for use in
the country by previous studies.
The average mathematics score
was 27 out of 100. The average
science score was 34 out of 100.
18

Only 1 percent of students scored
over 80 in either subject, thereby
demonstrating what researchers
called “excellent understanding.” Girls
slightly outperformed boys in science
and tied boys in mathematics.
The average score in private schools
was higher than in public schools, but
did not exceed 40 in either subject. The
average score in Punjab was the highest
among the country’s regions, but did not
exceed 40 in either subject. In total, 78
public schools and 75 private schools
participated in the study. Eighty percent
of students were the children of parents
with a high school certificate or less.
Only one in 20 eighth graders could
correctly answer the following question:
“There are thirty students in a class. The
ratio of boys to girls in the class is 2:3.
How many boys are there in the class?”

Only one in 50 could convert “ten
million, twenty thousand and thirty”
into numeric form. Fewer than one in
10 could identify the reason that the
heart beats faster during exercise.
“Science and mathematics education
are in dire need of attention from
practitioners and policymakers,” said
Assistant Professor Nusrat Fatima
Rizvi, a study co-principal investigator.
Researchers found that multiple
factors were significantly correlated with
students’ learning outcomes. In
increasing order of importance, those
factors were high-quality teaching
practices, a student’s mother having a
bachelor’s or master’s degree (a father’s
educational attainment was relatively
less important), only one language
being used in the classroom, attending
private school and going to school in
Punjab. Surprisingly, students tended

to learn less from experienced teachers
than from those new to the profession.
They also tended to learn less
from teachers with a degree in
education, compared to teachers
with a degree in another field.
The researchers visited the classrooms
of 589 teachers to assess the quality
of their instruction. The teaching
practices of nearly 9 in 10 were
graded weak, and roughly 1 in 10
were graded mediocre. No teachers
exhibited what the researchers
described as good teaching practice.
“In most classrooms, teachers spend
their time reading and explaining
words from the textbook instead of
encouraging students to ask questions
or participate in activities that bring
concepts to life,” said Associate
Professor Sadia Bhutta, a study co-

principal investigator. “This results
in poor understanding of concepts
and poor performance on tests.”
Among the study’s notable findings
was that students in monolingual
classrooms – where the textbook,
teaching and examinations were
all in one language – outperformed
those in multilingual classrooms.
Researchers also interviewed teachers
to understand the challenges they
face. The discussions revealed the
urgent need to provide teachers with
professional development opportunities
to improve both their subjectmatter knowledge and their ability
to reflect on their own pedagogy.
IED has repeatedly demonstrated that
high-quality professional development
can make a major difference for teachers

and students. To take one example,
Assistant Professor Munira Amirali
recently helped grade four teachers in a
low-fee private school to teach fractions
in a more engaging fashion, using
simple visual aids. Her work enabled
teachers to cover in a single lesson what
had previously taken three lessons. It
also led to two teachers participating
in a panel session at the International
Congress on Mathematics Education.
“Children look forward to science and
mathematics lessons when they are
given the chance to discover rules and
patterns for themselves,” Professor
Amirali said. “My goal is to inspire
teachers to involve students in their
learning so that every class is full of
the joy of learning something new.”
Professor Amirali’s study was funded
by AKU’s University Research Council.
19

Pakistan’s shortage
of mental health
professionals makes
innovative efforts
to expand access to
counselling necessary.

A new strategy for
improving mental
health in Pakistan
Mobile phone app in hand, community
health workers will provide counselling

20

AKU researchers will collaborate with
the Government of Sindh to increase
access to mental health services by
training community health workers
to provide basic counselling during
household visits with the help of
a mobile phone app. Given that
Pakistan has just one psychiatrist
for every 500,000 people, such
innovative efforts to expand access to
counselling are urgently necessary.

be trained using the World Health
Organization’s Mental Health Gap
intervention guide, which is designed
to enable non-specialists to provide
basic mental health services.

AKU’s project will be conducted in
the Badin District of Sindh, which has
the second-highest suicide rate in the
province. Trained data collectors will
survey approximately 350 households
to identify individuals suffering
from anxiety or depression who are
willing to participate in the study.

The LHWs will then use a mobile phone
app that includes scripts, video and
audio to provide monthly counselling
sessions for six months to individuals
who screen positive for anxiety or
depression. Among other things,
sessions will educate participants
on the causes of depression and
anxiety and the steps they can take
to alleviate symptoms, and provide
breathing and coping exercises. The
app will also assist LHWs in tracking
cases and in determining if someone
should be referred to a specialist.

Approximately 80 Lady Health Workers
(LHWs) and their supervisors will

Lady Health Workers are governmentemployed community health workers.

There are roughly 90,000 of them across
the country. Each makes monthly
visits to households in her community
to provide basic primary care.

of mental health professionals in
resource-limited countries around the
world, such evidence is badly needed
not only in Pakistan but globally.”

The app, known as mPareshan, is being
developed by the research team and
the Aga Khan Development Network’s
Digital Health Resource Centre, which
is based on AKU’s Karachi campus
and which previously developed a
mobile phone app for LHWs that is
being used in Gilgit-Baltistan. Pareshan
means worried or distressed in Urdu.

Researchers will evaluate changes in
participants’ depression and anxiety
scores, and in the knowledge and
skills of LHWs and their supervisors.
Discussions with stakeholders will help
identify factors that could facilitate or
hinder expansion of the intervention.

“This will be a pioneering study that
generates evidence on whether
community health workers can help
to address anxiety and depression in
vulnerable communities,” said Professor
Fauziah Rabbani, Associate Vice
Provost, Research and the project’s
principal investigator. “Given the lack

The study is being conducted by
faculty in the Community Health
Sciences Department in collaboration
with the University’s new Brain and
Mind Institute. It is one of numerous
interventions involving the Lady Health
Worker Programme that AKU has
carried out over the last two decades.
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Study links
maternal nutrition
and child health
Researchers are set to investigate the
impact of a range of interventions

AKU researchers are set to generate
much-needed evidence regarding
whether providing pregnant and
breastfeeding women with nutritional
supplements can improve the health
and development of their babies.
When women are undernourished
during pregnancy and breastfeeding,
it leads to their children being stunted
or underweight. That has major
implications for children’s long-term
health and well-being. But there is a
paucity of evidence regarding how
best to improve maternal nutrition
and thereby children’s development.
In addition, more evidence is needed
to determine if, as a recent large
study indicated, administering the
antibiotic azithromycin prophylactically
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to young children reduces mortality.
The study, known as MUMTA (mumta
means maternal love in Urdu), will
evaluate both a set of nutritional
interventions and the prophylactic
use of azithromycin. It is taking
place in Rehri Goth, a low-income
fishing community where AKU has
been conducting community health
research and operating free clinics
for more than 15 years. Over 2,800
women are being enrolled in the
study, which consists of two multiarm randomized controlled trials: one
involving pregnant women and another
involving breastfeeding women.
“We’ve witnessed how maternal
malnutrition as well as infections in
pregnant women and their infants

are impacting health in Rehri Goth,”
said Associate Professor Fyezah
Jehan, principal investigator of the
study. “Malnutrition’s harmful effects
span generations, as malnourished
mothers are more likely to give
birth to underweight babies.”
Trial 1, which focuses on pregnant
women, consists of four arms. Arm
A represents a control group that will
receive nutrition counselling. Arm B will
receive counselling as well as a highprotein nutritional supplement twice a
day for six months. Arm C will receive
the same interventions as Arm B but
also receive a dose of azithromycin.
Arm D will receive all of the above
interventions as well as the vitamins
choline and nicotinamide, which are

known to promote brain development.
Researchers will assess the impact of
the different interventions on babies’
birth weight and length and their
achievement of neurodevelopmental
milestones up to two years of age.
By performing magnetic resonance
imaging (MRIs) on infants born to study
participants, researchers will provide
new insights into which interventions
most effectively promote the growth and
structural development of a child’s brain.
Trial 2 is enrolling women who are
breastfeeding and will consist of
three arms. The first arm will be a
control group receiving only nutrition
counselling (the same as Arm A in
trial 1). The second arm will receive
counselling plus the same nutritional

intervention as Arm B in trial 1. This
will enable researchers to answer
a question that few if any studies
have addressed: whether nutritional
supplements are more effective when
delivered prior to birth or after birth.
In the third arm, babies, rather than their
mothers, will be given azithromycin.
This will help researchers assess

The study will be one
of the first to assess
whether nutritional
supplements are most
effective when delivered
before or after birth.

whether azithromycin is best delivered
through the placenta or directly to
the child. Malnourished mothers tend
to produce insufficient or low-quality
breast milk, hindering children’s
growth. Trial 2 will shed light on
whether nutritional supplementation
can enhance the quality of breast
milk and children’s growth.
The MUMTA study is being funded by
the Bill & Melinda Gates Foundation.
It is a partnership between AKU
and VITAL Pakistan Trust.
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Neonatal mortality fell
by 17 percent, to 24
deaths per 1,000 live
births from 29 deaths.

Major project yields
sharp fall in newborn
and child mortality
A US$ 25 million, Gates Foundation-funded
project has saved numerous lives

A large-scale public-private collaboration
led by AKU significantly reduced
neonatal and child mortality in eight
rural districts in Punjab, Balochistan
and Sindh in its first two years, saving
numerous lives. In total, the districts
are home to 14 million people.
Funded by a US$ 25 million grant from
the Bill & Melinda Gates Foundation,
the Umeed-e-Nau (New Hope)
project involves 219 public health
facilities, 110 private health facilities,
6,000 Lady Health Workers (LHWs),
22,000 women’s support groups and
6,000 village health committees.
Umeed-e-Nau is the largest
implementation study of its kind
undertaken in Pakistan to date. It
involves training LHWs and other health
workers to deliver evidence-based
interventions and equipping them with
new manuals, protocols and improved
job aids; providing health workers
with essential medical supplies such
as amoxicillin; educating families to
adopt healthy practices, including
timely care-seeking and immunization;
implementing interventions to empower

adolescent girls and young women;
and expanding services to underserved
areas. The bulk of these initiatives
are implemented through existing
government staff and facilities, making
them sustainable in principle. In all
districts, robust information and data
collection systems were instituted,
along with independent monitoring.
Activities were initiated in December
2017. As of January 2020, the neonatal
mortality rate in the eight districts
had declined by 17 percent, to 24
deaths per 1,000 live births from 29
deaths. The under-5 mortality rate
declined by 12 percent, to 76 deaths
per 1,000 live births from 86 deaths.
The reductions are significantly larger
than those seen in other areas of
Pakistan in the same time period.
Major improvements were also seen in
the percentage of women receiving at
least one antenatal care visit, delivering
in facilities and breastfeeding exclusively.
The percentage of children under the age
of 2 who were fully immunized increased
to 42 percent from 23 percent. Over
the next two years, two surveys will be

performed to assess the project’s impact
prior to its completion in December 2023.
“The early results are quite impressive,”
said Professor Zulfiqar Bhutta, the
project’s principal investigator and the
Founding Director of AKU’s Centre
of Excellence in Women and Child
Health. “Whether the impact will be
sustained in our upcoming surveys
remains to be seen. In the meantime,
we are actively sharing results with
government health officials and making
the case that with the right strategies
it is possible to dramatically improve
newborn and child survival.”
The impact of Umeed-e-Nau is already
being felt beyond participating districts.
As part of the project, the curriculum
used to train LHWs in Sindh was revised,
and other provinces have approached
AKU to assist in revising LHW curricula.
The project is also generating evidence
on innovative interventions, including a
conditional community-based financial
incentive to increase practices that
can reduce childhood pneumonia and
diarrhea, such as immunization.
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COVID-19 Research
The novel coronavirus remains the most
pressing challenge facing the world. In
Asia and Africa, AKU is at the forefront
of the effort to better understand the
virus and its impact, prevent its spread
and identify new treatments.
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Clinical trials assess
COVID-19 vaccines
and treatments

Meplazumab

Tocilizumab
AKU was one of only two centres in
Africa to contribute to Genentech’s
EMPACTA study, which assessed the
use of tocilizumab (Actemra), an arthritis
drug, to treat hospitalized patients with
COVID-associated pneumonia who
were not responding to standard care.
Tocilizumab reduced the likelihood
that patients would be placed on a
ventilator or die. The drug received
emergency use authorization from the
U.S. Food and Drug Administration.
Study results were published in The
New England Journal of Medicine.

Evidence from AKU boosts the search
for pandemic-fighting innovations

A dozen clinical trials of COVID-19
vaccines, therapeutics and
diagnostics are underway or have
been completed at AKU, with several
innovations already in wide use.
Prior to the pandemic, the University
had never conducted a phase III vaccine
clinical trial, a complex endeavour
to assess the safety and efficacy
of a vaccine in which thousands of
participants are injected with the
vaccine or a placebo. Nor had any
institution in Pakistan. But having built
its capacity to conduct such trials
with the support of PATH, a global
public-health nonprofit, and having
successfully completed a phase III
trial of CanSino’s COVID-19 vaccine,
AKU’s Clinical Trials Unit is drawing the
attention of researchers and vaccine
manufacturers around the world.
That matters because it is important
to determine the effectiveness of
vaccines in low- and middle-income
countries, as well as high-income
countries. Increasing the number of
sites able to conduct phase III trials
can also increase the speed with
which vaccines are rolled out globally.
The participation of Asia and Africa
in assessing vaccines also reinforces
their claim to a fair share of vaccines.
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CanSino Vaccine
In Karachi, AKU enrolled 3,000
participants in a multi-country,
30,000-participant, phase III trial
of CanSino Biologics’ single-dose
COVID-19 vaccine. The trial found the
vaccine was 66 percent effective in
preventing symptomatic cases and 91
percent effective in preventing severe
disease. In Pakistan, 10 million doses
have been administered so far. AKU
is now contributing to a new phase III
trial in which participants will receive
a booster shot of the vaccine.

Sanofi Vaccines
In Nairobi, AKU will contribute to a
multi-country, phase III trial of two
formulations of a protein-based
vaccine developed by Sanofi and
GlaxoSmithKline. One version has been
specially formulated to target the beta
variant that emerged in South Africa.
Existing vaccines are less effective
against that variant than others.

Nasal Swab
The University will soon be involved
in judging the effectiveness of
a novel, nasal swab based test,
with AKU being the only centre in
Pakistan involved in the trial.

Developed by China’s Pacific Meinuoke,
meplazumab is a monoclonal antibody
that could prevent entry of the novel
coronavirus into human cells and could
also inhibit inflammation in the body
due to COVID-19. AKU is participating
in a phase II/III trial assessing the use
of the drug in hospitalized patients with
COVID-19. Pacific Meinuoke hopes
to recruit at least a dozen centres
in multiple countries to the study.

Chloroquine/Hydroxychloroquine
AKU is the only centre in Pakistan
involved in Oxford University’s
14-country COPCOV study, the
world’s largest trial of the use of
chloroquine and hydroxychloroquine
as prophylactics to reduce the
risk that health care workers
will contract COVID-19. The
University has recruited nearly 400
participants, almost one-quarter of
the study’s total, as of July 2021.

SIR-I
AKU is participating in a phase 1b
trial of SIR-I, a receptor-interacting
protein kinase-1 inhibitor meant to treat
moderate to advanced complications
from COVID-19. The drug was
developed by Sironax, a Chinese/
American company. AKU is one of two
centres in Pakistan involved in the study.

Radiotherapy
Vaccine Mixing
In Karachi, AKU is participating in
two phase III trials that are evaluating
the effectiveness of a mix-and-match
approach to COVID-19 vaccination –
that is, giving someone one vaccine
and then later using a second vaccine
as a booster shot. A study by Oxford
University is assessing combinations
of the Oxford-AstraZeneca, PfizerBioNTech, Moderna and Novavax
vaccines. The University is also
participating in a trial under which
individuals who have received the
Sinopharm or Sinovac vaccine will
receive a booster shot of a protein
sub-unit vaccine manufactured
by Livzon Mabpharm of China.

Solidarity Trials
AKU was one of 405 hospitals in 30
countries to contribute to the World
Health Organization’s Solidarity trial,
which found that in hospitalized patients
with COVID-19, four repurposed antiviral
drugs had little or no effect on mortality,
initiation of ventilation or duration of
hospital stay. AKU is now participating
in the next phase of the trial, dubbed
Solidarity PLUS, which is assessing the
use of three other repurposed drugs
– artesunate, imatinib and infliximab.

AKU is conducting a pilot-phase
study into whether whole-lung, lowdose radiation therapy can improve
outcomes for hospitalized patients with
COVID-19 pneumonia and severe acute
respiratory syndrome. Researchers
hypothesize that radiotherapy could
reduce the inflammation in patients’
lungs. Up to 20 patients will be
recruited to the trial at the Aga Khan
University Hospital, Nairobi.

Panbio Rapid Test
AKU was one of two sites outside of
the United States, and the only centre
in Pakistan, to participate in a study
assessing Abbott’s Panbio rapid antigen
self-test for COVID-19. The test can
deliver results in as little as 15 minutes,
significantly faster than PCR tests.
In Germany and France, schools are
using the test for students and staff.
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Understanding
the epidemiology
of COVID-19 in
rural Africa
In Kenya, researchers are using a new
technology for antibody testing

"We don't really know
what level of exposure
there has been in these
rural communities,"
Professor Stanley
Luchters said.

AKU’s Department of Population
Health in Nairobi aims to shed light
on the epidemiology of the novel
coronavirus in rural sub-Saharan Africa
through a pair of studies conducted
in Kenya’s Kilifi County, where the
University has been working to track
and improve health for years.

of Population Health and the study’s
principal investigator in Kenya. “It
could be that 60 percent have been
exposed, but maybe it’s 10 to 15
percent and they’re at risk for new
waves. It’s also important that our
understanding of the virus reflects
its behaviour in diverse settings.”

The studies will help to establish
the virus’s transmissibility, how long
antibodies against it last, rates of
asymptomatic infection, risk factors
for infection and more. They will also
provide information on participants’
compliance with preventative measures
and willingness to get vaccinated. And
they will assess the performance of
a new device that makes it possible
to capture blood samples and store
them for antibody testing at a later
date, without the need for cold storage.
With Nanjing Biopoint’s VLPlasma
device, health workers take blood
with a fingerprick and a dried plasma
spot is stored for future analysis.

The first study is a small household
cluster survey. In households where
one member has tested positive for the
virus, researchers will test all members
for the virus and take blood samples on
a weekly basis for 28 days. Part of the
purpose is to determine the reliability
of the VLPlasma device, which will be
done by testing both dried plasma spots
and blood drawn in standard fashion
from each subject. An identical study
is being conducted in South Africa by
the University of the Witwatersrand.

“We don’t really know what level of
exposure there has been in these rural
communities,” said Professor Stanley
Luchters, Chair of the Department

The second study involves conducting
periodic testing of roughly 1,600
individuals in 487 households to
determine how many have antibodies
to the virus as a result of a past
exposure and how many have new
infections. Testing will be conducted
every six weeks for six months, and

other health data will be collected
simultaneously. The households have
been randomly selected from 18,000
households that AKU visits every six
months as part of its ongoing health
and demographic surveillance project
in the Kaloleni/Rabai area of Kilifi.
Both studies follow the standardized
UNITY protocols for COVID-19 seroepidemiological investigations developed
by the World Health Organization.
The protocols are meant to facilitate
research that is comparable across
countries, helping to rapidly answer
key questions about the virus.
AKU’s local collaborators are the Kilifi
County Department of Health, the
Kenya Medical Research Institute-Kilifi
and the Aga Khan Health Services. Its
international partners are Heidelberg
University’s Heidelberg Institute of
Global Health, the University of the
Witwatersrand’s Wits Reproductive
Health and HIV Institute, the Burnet
Institute in Australia, Nanjing Biopoint
in China and the Barcelona Institute
for Global Health. The studies are
funded by the European & Developing
Countries Clinical Trials Partnership.
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Interferons offer
protection against
SARS-CoV-2
The protein is already used to treat
other viral infections

Individuals who contract COVID-19
but suffer no symptoms may be
the beneficiaries of their body’s
production of virus-fighting proteins
called interferons, according to
research by AKU scientists.
Using chip-based microarray
technology that allowed them to
examine more than 21,000 genes at
once, researchers compared COVID-19
patients with minimal symptoms to
those with symptomatic mild and severe
disease. They found key differences in
the intensity of interferon-stimulated
genes that are critical for restricting
viral replication and persistence.
“Interferon has been widely
discussed, and other studies have
shown that in individuals with severe
COVID-19 the interferon response
is dysregulated, exacerbating the
disease,” said Professor Zahra Hasan,
the study’s principal investigator.

“But few studies have examined the
interferon response in asymptomatic
individuals. Our research suggests
that interferons likely drive clearance
of SARS-CoV-2 infection.”
Laboratory-made interferons have long
been used to treat several types of
viral infections, including hepatitis B.
AKU’s research suggests that this
commonly available treatment could
help fend off the novel coronavirus in
the early stages of infection, providing
accessible therapy for the disease.
AKU is the only institution in
Pakistan using chip-based
microarray technology for research
and clinical diagnostics.
Funding for the study was provided
by a Rapid Research Grant for
COVID-19 from the Higher Education
Commission of Pakistan.
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Kenya’s health
system shows
signs of resilience
Study finds the pandemic’s
impact on reproductive health
was relatively short-lived

Indicators of sexual and reproductive
health in three Kenyan counties returned
to near-normal levels after declining for
several months early in the pandemic,
according to AKU researchers, who said
the finding demonstrates the resilience
of the country’s health system.
The researchers analyzed health facility
data from Nairobi, Mombasa and Kilifi
counties collected by the Ministry of
Health. They also interviewed 65 health
workers and government officials and
conducted 33 focus group discussions
with community members and leaders
in an effort to better understand the
trends their data analysis uncovered.
The study concluded in June 2021.
Yet the news was not all good.
Researchers flagged a worrying
number of cases of sexual and genderbased violence during the 10 months
starting in June 2020, especially in
Nairobi County. There, the number of
individuals seeking help at health care
facilities for such violence in March
2021 was by far the highest in any
month dating back to January 2018.

Most interviewees attributed the
increase to the stresses associated
with the pandemic and to families
being trapped at home. Researchers
hypothesized that the increase in
violence may have been even larger
than the data indicates, considering
that some victims were likely unable
to seek care due to curfews and other
restrictions, or were unwilling to do so
because they feared being exposed to
the virus while visiting a health facility.
“Our goal was to provide evidence that
can help government and society to
address the unintended consequences
of pandemic mitigation measures such
as stay-at-home orders,” said Professor
Marleen Temmerman, Director of

Professor Marleen
Temmerman and her
colleagues noted an
increase in sexual and
gender-based violence.

AKU’s Centre of Excellence in Women
and Child Health, East Africa and the
study’s principal investigator. “An
increase in sexual and gender-based
violence is one such consequence.”
The study assessed data on family
planning, pregnancy care and
outcomes, the number of women
delivering in health facilities, antenatal
and postnatal care, HIV care and
adolescent sexual and reproductive
health. The data did not make it clear if,
as researchers had hypothesized, the
pandemic has resulted in a baby boom,
or what its impact on maternal and
newborn mortality has been. The study
did find that the number of adolescents
and young people accessing
contraceptives declined and did not
rebound. Researchers said that could be
because the closure of schools, youth
organizations and clinics serving young
people reduced access to information
and family planning services.
Funding for the study was provided by
the United Nations Population Fund.
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COVID-19
increases
pregnancy
complications

Months later,
COVID-19
survivors still
suffer lung
problems

AKU contributed to a global
study that found COVID-19
is a major threat to pregnant
women and newborns

Pregnant women who contract
COVID-19 face a much higher
risk of serious pregnancy-related
complications, according to an
18-country study to which AKU
contributed. The study was one of
the first to quantify the effects of
COVID-19 in pregnancy and to provide
robust evidence for the potential
need to vaccinate pregnant women.
The study found that infected women
were 22 times more likely to die and
50 percent more likely to experience
pregnancy-related complications
than expecting women unaffected
by COVID-19. Infection increased
the risk for pre-eclampsia/eclampsia,
severe infections, admission to an
intensive care unit, preterm birth and
other complications. Newborns of
infected women were nearly three
times more likely to experience severe
36

complications, such as admission
to a neonatal intensive care unit.
Researchers enrolled 2,130 women
from 43 hospitals in low-, middle- and
high-income countries. Each woman
affected by COVID-19 was compared
to two non-infected pregnant women
giving birth at the same time in the
same hospital. The risk of complications
was especially high in women
experiencing fever and shortness
of breath, a finding that researchers
said should influence clinical care.
The study, known as INTERCOVID,
was led by the University of Oxford.
Twelve percent of babies born to
women with COVID-19 tested positive
for the virus. Caesarean delivery was
associated with a positive neonatal test
for the virus. Breastfeeding was not.
AKU recruited over 300 pregnant

women in Pakistan to the study.
Pakistani women with COVID-19 and
their babies had better outcomes
than those elsewhere, with fewer
pre-term births, intensive care unit
admissions and other adverse
incidents. “Our findings merit further
exploration as to why mothers and
newborns in Pakistan fared better than
in the rest of world,” said Associate
Professor Shabina Ariff, primary
investigator of the study in Pakistan.
The US Centers for Disease Control
and Prevention has recommended
vaccination for pregnant women.
The World Health Organization has
advised vaccination for pregnant
women “when the benefits …
outweigh the potential risks.”

Study adds to the
evidence on “long COVID”

More than 4 in 10 patients hospitalised
for moderate or severe COVID-19
at the Aga Khan University Hospital
in Karachi were still suffering from
impaired lung function six months
later, according to an AKU study.
The prospective cohort study analyzed
67 individuals aged 15 years or older.
Participants were examined three
months and six months after infection,
and lung damage and pulmonary
function was assessed with chest x-ray,
spirometry and diffusing capacity of
the lungs for carbon monoxide (DLCO),
which is a test to measure the extent
to which oxygen passes from the air
sacs of the lungs into the blood.
After three months, 21 percent had
mild lung function impairment, 13
percent had moderate impairment
and one study participant had severe

impairment. After six months, 38
percent had mild impairment, 3 percent
had moderate impairment and one
participant had severe impairment.
“The fact that after six months more
than 40 percent of individuals in
our study still had not completely
recovered their normal lung function
is alarming,” said Assistant Professor
Sonia Qureshi, the study’s principal
investigator. “It suggests that as a

Six months after
infection, 38% had mild
impairment, 3% had
moderate impairment
and one participant had
severe impairment.

country Pakistan needs to take steps
to provide access to rehabilitative
care for survivors of COVID-19.”
That COVID-19 can lead to inflammation
and scarring of the lungs is well
known. But the percentage of infected
individuals for whom symptoms such
as coughing and difficulty breathing
persist, and how long they last, remains
unclear, with studies ongoing.
A University of Oxford study of nearly
275,000 COVID-19 survivors that was
based on electronic health records
found that nearly 8 percent suffered
from abnormal breathing in the three
to six months after their diagnosis.
Funding for the AKU study was provided
by the Bill & Melinda Gates Foundation.
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Accelerating learning
in Tanzania following
school closures
IED helped teachers make up for instruction
time lost due to the pandemic

The three-month closure of public
schools in Tanzania in 2020 due to
the pandemic had especially negative
consequences for primary students
in Lindi, a marginalized region where
AKU’s Institute for Educational
Development, East Africa (IED) has
been working since 2012. Students
learned little during the closure, as
families lacked access to learning
materials, four out of five parents had
only a primary education and schools
were unprepared to support learning
at home, according to an IED survey.
To help primary schools make up for
lost time, the Institute trained teachers
in methods for accelerating learning
for students in standards 1-3 (ages
7-9), such as delivering lessons that
enable learning in multiple subjects.
For example, a hygiene lesson might
also help students learn to count. IED
also created teaching materials for
teachers to use in the classroom.
In addition, Institute faculty developed
school management guidebooks for
head teachers to assist them in dealing
with the pandemic and other potential

future emergencies, and provided
training to help head teachers support
accelerated learning in their schools.
In total, the Institute worked with
teachers and head teachers in more
than 70 schools, impacting 11,500
students during the six-month project.
IED also engaged social workers and
head teachers to help them address
a range of issues affecting older
youths during and after the closure
of schools. These included early
pregnancy, students dropping out of
school and gender-based violence.
An evaluation showed the project
had a positive impact, with teachers
demonstrating improved competency
in developing and using ageappropriate learning resources
and assessment practices. Head
teachers also improved their ability
to monitor teaching and learning in
their schools and to collaborate with
parents and non-school officials.
The project was funded by
Global Affairs Canada.
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Exploring the
impact of the
pandemic on
women's health
Studies will inform policy and
practice in Pakistan and elsewhere

AKU’s community health sciences
and nursing faculty in Pakistan are
contributing to two multi-country
studies that will shed light on the
impact of COVID-19 on pregnant
women and their babies and inform
efforts to meet the sexual and
reproductive health needs of women
during the pandemic. The studies will
also provide evidence on the level of
protection that vaccination against the
virus provides to pregnant women.

In Pakistan, the
study will enroll
3,000 women from
AKU hospitals and
public hospitals in
three provinces.

The two studies will be carried out in 12
countries, including Pakistan, under the
auspices of the Human Reproduction
Programme (HRP), a joint project of
the World Health Organization (WHO),
the World Bank and multiple United
Nations agencies. HRP coordinates and
builds capacity to conduct research
in sexual and reproductive health
around the world. As the HRP Alliance
Hub for the Eastern Mediterranean
region, AKU will lead the studies in
Pakistan. The University will also
support participating institutions in other
countries by sharing data, guidelines
and standard operating procedures.
The first study will compare pregnant
women infected with SARS-CoV-2 to

pregnant women not infected with the
virus, assessing their health and that
of their babies. The second study will
examine the ability of health systems
to provide sexual and reproductive
health services during the pandemic.
In Pakistan, the first study will enroll
3,000 pregnant women from AKU
hospitals and four large tertiary public
hospitals in three provinces. Vaccinated
and unvaccinated women will be
included. Researchers will track their
health until six weeks after birth and
will collect samples of breast milk and
other bodily fluids. Among other things,
this will generate evidence on whether
COVID-19 can be transmitted during
pregnancy from a mother to a foetus.
“Besides assessing the outcomes
in COVID-19 positive and negative
expecting women, our study
will also help us understand and
document the impact of vaccinations
on pregnancy outcomes,” said
Professor Sarah Saleem, the study’s
principal investigator in Pakistan.

Service Availability and Readiness
Assessment tool to evaluate whether
the facilities have the infrastructure,
human resources and equipment to
meet women’s health needs. They will
also conduct more than 100 interviews
and conduct 18 focus groups with
women, their partners and health
care providers to understand barriers
to accessing care and to evaluate
how the pandemic has impacted
women’s mental health, contraceptive
use and personal autonomy.
“Access to family planning saves lives
and has a great impact on women’s
economic empowerment and mental
well-being,” said Professor Rozina
Karmaliani, co-principal investigator
and Dean of the School of Nursing and
Midwifery. “Our goal is to boost the
resilience of the health care system
and to promote men’s awareness and
engagement in family planning and
in women’s health care issues. Since
men have been identified as crucial in
decision-making in families, changing
their mindsets can help to bring about
the positive impact we wish to see.”

The second study will survey nine rural
and urban health facilities across Sindh
province. Faculty will use the WHO’s
11
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“I did not have
money to buy
a mask”
Pregnant women in Mbale report
the pandemic has been difficult

Pregnant women in Uganda’s Mbale
District have experienced severe
difficulties in accessing health care
during the pandemic, according to a
small qualitative study by Mary Grace
Nakate, an assistant professor in AKU’s
School of Nursing and Midwifery,
East Africa, and three co-authors at
Liverpool John Moores University.
For her study, Nakate interviewed
14 women and men in a rural area of
Mbale in eastern Uganda in October
2020. Interviewees reported that
they had great difficulty accessing
care due to curfews, bans on public
transport and other restrictions.
One woman reported that she almost
bled to death after giving birth at home.
Participants reported being turned away
from a health facility for lacking a mask
and spending all day at a facility only to
have staff leave early due to the curfew.
Even when they were able to access
care, interviewees found health workers
reluctant to approach them or conduct
examinations due to fear of the virus.
Nakate’s co-authors are Jane
McKendrick, Sean Mackay, Eunice
Ndirangu and Valerie Fleming.

“I missed most of the appointments because of
the process of getting travel documents and lack
of money … I did not have money to buy a mask.
I sat at the health facility with my sick child
whose condition was worsening each minute
that passed until someone gave me a mask and I
entered the hospital.”

“I had to look for transport. Meanwhile, the
baby’s condition was worsening, the temperature
was high, the baby was vomiting and it had
diarrhea … We were supposed to go back to
the hospital after one week, but I never wanted
to go through the same experience again.”

“These health workers distanced themselves
from us. I once had something to tell them, but
I could not tell them because I sat very far from
the health worker who attended to me. She never
even examined me. She asked me questions
when everyone was hearing. I just told her that
I had a headache, yet I had another issue.”

“I felt like not going back to the clinic because
the love and care I used to receive from the
health workers there were no longer evident.”

“I am worried about my baby. I delivered
from home, yet I was supposed to deliver
from the hospital. He did not get the syrup
that prevents HIV to the baby.”

“I had no money. I had no employment. That is
why my sister died. We could not transport her to
the hospital to deliver in time.”
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Research facilities,
oversight and ethics
ETHICS REVIEW BOARD

JUMA LABORATORY
AKU’s Juma research laboratory is
facilitating 30 research projects in its
Biosafety Level 2 and Biosafety Level
3 facilities. These projects focus on
maternal, neonatal and child health,
environmental enteric diseases,
the effects of vaccines and drugs,
dental stem cells, cancer research
and COVID-19. Among these, eight
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ongoing research projects specifically
focus on COVID-19 prevalence and
immuno-dynamics and their correlation
with pregnancy outcomes. Inside
the facility, a biorepository set up in
November 2020 continues to archive
COVID-19 samples in a dedicated
ultra-low temperature freezer. A new
next-generation genomic sequencing
facility/enclosure utilizes the Illumina
MiSeq machine to conduct critical
research to understand the nature and
transmissibility of COVID-19 variants.
The laboratory also houses equipment
such as an automated nucleic acid
extractor, TapeStation, shaking
incubator, enzyme-linked immunoassay
(ELISA) reader and semi-automated
microtome and refrigerated centrifuges.
Recently, the lab has developed
new standard operating procedures,
guidelines and training to minimize the
risk of exposure and ensure workplace
safety during the pandemic.

ANIMAL RESEARCH FACILITY

INSTITUTIONAL BIOSAFETY
COMMITTEE
The Institutional Biosafety Committee
(IBC) develops standard operating
procedures and ensures compliance
with biosafety practices based on
national and international guidelines.
From January to September 2021,
the Committee reviewed 104 project
proposals and 18 material transfer
agreements. The IBC aims to initiate
blended biosafety training programmes,
leading to certification and biosafety
and biosecurity awareness among
researchers at AKU.

Following the development of specific
standard operating procedures for
animal work during COVID-19, the
Animal Research Facility has resumed
full operations after temporary
suspension of non-essential work
due to the pandemic. Overseen by
the Ethics Committee for Animal Care
and Use (ECACU), all projects at the
facility undergo a review process for
ethics, animal welfare and personnel
safety approval. Fourteen new and
three renewal applications have been
processed by ECACU in 2021 so far,
including undergraduate teachings and
research projects and grant funded
research projects. The Committee also
provides various training opportunities.
The annual workshop, Principles
of Laboratory Animal Science, was
conducted online in 2021 due to
COVID-19, while the ongoing MPhil
Programme elective course, Laboratory
Animal Science, is taking place inperson. Working towards international
accreditation, the ongoing review
process has so far affirmed that the
functionality and design of the Stadium
Road Animal Research Facility is
consistent with international standards
and guidelines.

The Ethics Review Board (ERB) is an
independent body that reports to the
University Research Council and is
mandated to monitor ethical compliance
in research at AKU, standardize ethical
review processes across different
geographies and address appeal
cases. ERB has developed frameworks,
guidelines, standard operating
procedures and tools for ethical
monitoring of research projects, taking
into account the indicators for Joint
Commission International accreditation
as part of the monitoring tool. In 2021,
64 studies have been monitored at
the Faculty of Health Sciences in
Karachi, which is 20 percent of all active
ongoing projects. In July 2021, a selfassessment ethical monitoring tool was
developed by the ERB, aiming at 100
percent self-monitoring across AKU. In
addition, the ERB has proposed the inperson monitoring of ethical compliance
in 20 percent of all projects across AKU
campuses and across all disciplines.

PATENTS
A portable, low-cost emergency
ventilator developed by the
University has received a US patent
that recognises over 20 innovative
aspects of the device. The patented
device consists of a battery-operated
motor that automatically inflates and
deflates a medical-grade ambu bag
in line with a self-adjusting, propriety
algorithm that ensures a stable air
supply to patients suffering from
breathing difficulties. The Resuscitation
Automation Device (RAD) aims to act
as a bridge between manually operated
ambu bags – which can be difficult,
unreliable and distressing to use – and
expensive ventilators, which may not
be immediately available for critically ill
patients in some circumstances.
Clinical trials on the RAD are set to
begin soon to assess its safety and
efficacy among patients with respiratory
problems. The project team anticipates
the RAD will be launched a year after
the completion of clinical trials.
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Notable
publications
The following is a list of notable
articles by AKU faculty published
in peer-reviewed journals between
late 2020 (when the last AKU
Research Magazine was issued)
and late 2021. The vast majority
were published in journals with an
impact factor of six and above.

LANCET GLOBAL HEALTH:
EFFECTIVENESS OF TYPHOID
CONJUGATE VACCINE
Salmonella enterica serotype Typhi (S.
Typhi) is a major public health problem
in low-income and middle-income
countries. We aimed to investigate
the effectiveness and impact of the
typhoid conjugate vaccine Typbar-TCV
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against S. Typhi among children in an
outbreak setting of extensively drugresistant (XDR) S. Typhi in Pakistan.
23,407 children from a census registry
and surveillance system were included
in the vaccine effectiveness analysis.
Vaccine effectiveness was 55% (95%
CI 52–57) against suspected S. Typhi
(regardless of culture confirmation),
95% (93–96) against culture-confirmed
S. Typhi, and 97% (95–98) against
XDR S. Typhi. Typbar-TCV is effective
in protecting children against S. Typhi
infection in an outbreak setting, and
was able, with moderate deployment,
to curtail a major XDR S. Typhi outbreak
in a densely populated setting. The
vaccine shows efficacy against S. Typhi
irrespective of antimicrobial resistance.
Yousafzai MT, Karim S, Qureshi S, Kazi
M, Memon H, Junejo A, Khawaja Z,
Ur Rehman N, Ansari MS, Ali R, Ujjan
IU, Lohana HM, Memon NM, Hussain
M, Nigar R, Bar-Zeev N, Qamar FN.
Effectiveness of typhoid conjugate
vaccine against culture-confirmed
Salmonella enterica serotype Typhi in
an extensively drug-resistant outbreak
setting of Hyderabad, Pakistan: a
cohort study. Lancet Glob Health.
2021 Aug;9(8):e1154-e1162.

CLINICAL INFECTIOUS DISEASES:
BURDEN OF CULTURE-CONFIRMED
ENTERIC FEVER CASES
THE LANCET GASTROENTEROLOGY
& HEPATOLOGY: IDENTIFYING THE
LOWER AGE LIMIT FOR HEPATITIS C

THE LANCET HIV: HIV INFECTION
AMONG CHILDREN IN LARKANA
DISTRICT

A population-based cohort study is
being done in a highly endemic, periurban district of Karachi, Pakistan,
as part of a hepatitis C virus (HCV)
microelimination campaign. By
August 2020, 8,385 individuals had
been screened, of whom 632 (7·5%)
tested positive for HCV antibody.
399 (63·1%) of 632 had detectable
HCV RNA and 330 (52·2%) have
been linked to treatment. Pakistan is
preparing to embark on an ambitious
HCV elimination programme that
includes screening of nearly 158 million
individuals, of whom 45 million are
estimated to be adolescents. WHO
recommends testing all adults and
adolescents in populations with high
HCV seroprevalence. However, based
on our data, it might not be necessary
to screen individuals aged 12–17 years
in HCV elimination campaigns.

In April 2019, an HIV outbreak
predominantly affecting children
occurred in Larkana District, Sindh,
Pakistan. In this individually matched
case-control study, we sampled 406
cases (individuals aged <16 years
who had registered for paediatric HIV
care at the HIV Treatment Centre at
Shaikh Zayed Children’s Hospital in
Larkana city, Pakistan) and 406 controls
(individuals without HIV matched
by age, sex, and neighbourhood
residence, recruited through doorknocking at houses adjacent to case
participants). The predominant mode
of HIV transmission in this outbreak
was parenteral, probably due to unsafe
injection practices and poor blood
safety practices. General practitioners
across Pakistan need training and
systems support in reducing injection
use, and in providing safe injections and
transfusions only when necessary.

Hamid S, Abid A, Dore GJ. Identifying
the lower age limit for hepatitis
C screening in large elimination
programmes in highly endemic
areas. Lancet Gastroenterol
Hepatol. 2021 Feb;6(2):89-90.

Mir F, Nathwani AA, Simms V, Abidi
SH, Siddiqui AR, Hotwani A, Memon
SA, Shaikh SA, Soomro J, Shah SA,
Achakzai B, Furqan S, Saeed Q, Khan
P, Weiss HA, Mahmood SF, Ferrand RA.
Factors associated with HIV infection
among children in Larkana District,
Pakistan: a matched case-control study.
Lancet HIV. 2021 Jun;8(6):e342-e352.

CLINICAL INFECTIOUS DISEASES:
RESPIRATORY SYNCYTIAL VIRUSASSOCIATED MORTALITY AMONG
YOUNG INFANTS
Respiratory syncytial virus (RSV) is an
important cause of infant morbidity
and mortality and a potential target
for maternal immunization strategies.
However, data on the role of RSV in
young infant deaths in developing
countries are limited. We conducted a
community-based mortality surveillance
from August 2018-March 2020 for
infants ≤6 months in Karachi, Pakistan.
Our findings show that RSV has a
significant mortality burden in early
infancy in Karachi, Pakistan. Age, RSV
seasonality, and respiratory symptoms
were significant predictors of RSVassociated mortality. Our findings have
implications for clinical management of
young infants with cold-like symptoms,
policy development, and research
regarding maternal immunization
against RSV during pregnancy, in
resource-constrained, low-income, and
vaccine-hesitant populations.
Kazi AM, Aguolu OG, Mughis W,
Ahsan N, Jamal S, Khan A, Qureshi
HM, Yildirim I, Malik FA, Omer
SB. Respiratory Syncytial VirusAssociated Mortality Among Young
Infants in Karachi, Pakistan: A
Prospective Postmortem Surveillance
Study. Clin Infect Dis. 2021 Sep
2;73(Suppl_3):S203-S209.

The objectives of the study were to
characterize disease incidence among
patients with enteric fever. We report the
burden of enteric fever at selected sites
of Karachi, Pakistan. During September
2016 to September 2019, prospective
surveillance was conducted at inpatient,
outpatient, surgical departments,
and laboratory networks of Aga
Khan University Hospital, Kharadar
General Hospital, and surgery units of
National Institute of Child Health and
Jinnah Postgraduate Medical Centre.
Sociodemographic, clinical, and
laboratory data were obtained from all
suspected or confirmed enteric fever
cases. Overall, 22% (2,230/10,094) of
patients enrolled were culture-positive
for enteric fever. 94% (2,093/2,230)
of isolates were Salmonella Typhi and
6% (137/2,230) were S. Paratyphi.
15% of isolates multi-drug resistant
(MDR) to first-line antibiotics and
60% were extensively drug-resistant
(XDR), resistant to first-line antibiotics,
fluoroquinolones and third generation
cephalosporin. Enteric fever cases have
increased during the last 3 years with
large proportion of drug resistant S.
Typhi cases. However, the burden of
paratyphoid is still relatively low.

Yousafzai MT, Irfan S, Thobani RS, Kazi
AM, Hotwani A, Memon AM, Iqbal K,
Qazi SH, Saddal NS, Rahman N, Dehraj
IF, Hunzai MJ, Mehmood J, Garrett DO,
Saha SK, Andrews JR, Luby SP, Qamar
FN. Burden of Culture Confirmed Enteric
Fever Cases in Karachi, Pakistan:
Surveillance For Enteric Fever in Asia
Project (SEAP), 2016-2019. Clin Infect
Dis. 2020 Dec 1;71(Suppl 3):S214-S221.
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CLINICAL INFECTIOUS DISEASES:
ANTIMICROBIAL RESISTANCE IN
TYPHOIDAL SALMONELLA

CLINICAL INFECTIOUS DISEASES:
BURDEN OF ILEAL PERFORATIONS
AMONG SURGICAL PATIENTS

CLINICAL MICROBIOLOGY AND
INFECTION: COVID-19 ASSOCIATED
MUCORMYCOSIS

As a part of the Surveillance for Enteric
Fever in Asia Project (SEAP), we
measured the burden of antimicrobial
resistance (AMR) among confirmed
enteric fever cases in Bangladesh,
Nepal, and Pakistan. From September
2016-September 2019, SEAP recruited
study participants of all age groups
from its outpatient, inpatient, hospital
laboratory, laboratory network, and
surgical sites who had a diagnosis of
febrile illness that was either suspected
or blood culture confirmed for enteric
fever. We enrolled 8,705 blood culture
confirmed enteric fever cases. Although
antimicrobial resistance against S.
Paratyphi was low across the three
countries, there was widespread drug
resistance among S. Typhi, including FQ
non-susceptibility and the emergence
of XDR S. Typhi in Pakistan, limiting
treatment options. As typhoid conjugate
vaccine (TCV) is rolled out, surveillance
should continue to monitor changes in
AMR to inform policies and to monitor
drug resistance in S. Paratyphi, for
which there is no vaccine.

We aimed to characterize typhoidrelated ileal perforation in the context
of the population-based Surveillance
of Enteric Fever in Asia Project
(SEAP) in Bangladesh, Nepal and
Pakistan.Between September 2016
and September 2019, all cases of
nontraumatic ileal perforation with
a clinical diagnosis of typhoid were
enrolled from four tertiary care hospitals
in Karachi, two paediatric hospitals
in Bangladesh, and two hospitals in
Nepal. Although surveillance differed
substantially by country, one reason for
the higher number of ileal perforation
cases in Pakistan could be the
circulation of XDR strain of S. Typhi in
Karachi.

Mucormycosis is a life-threatening
infection that most commonly occurs
in patients with uncontrolled diabetes
mellitus and/or immunocompromised
status. Patients with severe to
critical coronavirus disease 2019
(COVID-19) infection have been recently
identified as an at-risk population
for mucormycosis with reports of
COVID-19-associated mucormycosis
(CAM) from many countries. Here, we
describe ten cases of CAM with high
mortality from Pakistan. We found that
mucormycosis can complicate severe
COVID-19, particularly in patients with
underlying uncontrolled diabetes and
those who receive systemic steroids.
Moreover, the case fatality rate was high
in this cohort. CAM remains an underrecognised entity given the difficulty in
diagnosing this infection in resourceconstrained settings. The study is
the first detailed description of CAM
cases from Pakistan and recommends
keeping a high index of suspicion in
patients with suggestive clinical findings
who have received steroids for severe
COVID-19.

Qamar FN, Yousafzai MT, Dehraj IF,
Shakoor S, Irfan S, Hotwani A, Hunzai
MJ, Thobani RS, Rahman N, Mehmood
J, Hemlock C, Memon AM, Andrews
JR, Luby SP, Garrett DO, Longley
AT, Date K, Saha SK. Antimicrobial
Resistance in Typhoidal Salmonella:
Surveillance for Enteric Fever in Asia
Project, 2016-2019. Clin Infect Dis.
2020 Dec 1;71(Suppl 3):S276-S284.
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Qazi SH, Yousafzai MT, Saddal NS,
Dehraj IF, Thobani RS, Akhtar A, Syed
JR, Kazi AM, Hotwani A, Rahman
N, Mehmood J, Andrews JR, Luby
SP, Garrett DO, Qamar FN. Burden
of Ileal Perforations Among Surgical
Patients Admitted in Tertiary Care
Hospitals of Three Asian countries:
Surveillance of Enteric Fever in
Asia Project (SEAP), September
2016-September 2019. Clin Infect Dis.
2020 Dec 1;71(Suppl 3):S232-S238.

Nasir N, Farooqi J, Mahmood SF,
Jabeen K. COVID-19 associated
mucormycosis: a life-threatening
complication in patients admitted
with severe to critical COVID-19 from
Pakistan. Clin Microbiol Infect. 2021
Aug 8:S1198-743X(21)00433-X.

JOURNAL OF THE AMERICAN
SOCIETY OF ECHOCARDIOGRAPHY:
CARDIOVASCULAR DYSFUNCTION
IN CHILDREN EXPOSED TO PREECLAMPSIA
The aim of this study was to assess
differences in cardiac and vascular
structure and function in children
exposed to pre-eclampsia in utero
compared with those of normotensive
mothers. This was a retrospective
cohort study that included children
2 to 10 years of age born to mothers
with and without exposure to preeclampsia in utero (n = 80 in each
group). Children in the exposed group
had a significantly higher prevalence
of stage 1 systolic and diastolic
hypertension (22% [n = 18] and 35% [n
= 18], respectively) compared with the
unexposed group (9% [n = 7] and 19%
[n = 15], respectively; P = .01). Children
in the exposed group also had higher
pulse-wave velocity compared with
those in the unexposed group (0.42 ±
0.1 vs 0.39 ± 0.1, P = .03). Subgroup
analysis revealed that changes in blood
pressure and pulse-wave velocity were
determined primarily by early-onset
pre-eclampsia. There was no significant
difference in cardiac morphology or
systolic and diastolic function between
the exposed and unexposed groups.
In utero exposure to pre-eclampsia
has an effect on vascular function in
children aged 2 to 10 years, related
primarily to early-onset disease. Routine
blood pressure screening should be
recommended for such children.
Hoodbhoy Z, Mohammed N, Rozi S,
Aslam N, Mohsin S, Ashiqali S, Ali H,
Sattar S, Chowdhury D, Hasan BS.
Cardiovascular Dysfunction in Children
Exposed to Preeclampsia During
Fetal Life. J Am Soc Echocardiogr.
2021 Jun;34(6):653-661.

ULTRASOUND IN OBSTETRICS &
GYNAECOLOGY: ROUTINE THIRDTRIMESTER ULTRASOUND
Our objective was to compare the
proportion of small-for-gestationalage (SGA) infants detected by routine
third-trimester ultrasound versus
those detected by selective ultrasound
based on serial symphysis-fundus
height (SFH) measurements (standard
care) in low-risk pregnancy. This was
an open-label randomized controlled
trial conducted at a hospital in Kenya
between May 2018 and February 2020.
The detection rate of SGA infants by
routine third-trimester ultrasound versus
that by standard care was 52.8%
(19/36) vs 7.7% (2/26) (P < 0.001) and
the specificity was 95.5% (191/200)
and 97.9% (191/195), respectively (P
= 0.08). In low-risk pregnancy, routine
ultrasound performed between 36
+ 0 and 37 + 6 weeks is superior to
selective ultrasound based on serial
SFH measurements for the detection of
true SGA, with high specificity.
Wanyonyi SZ, Orwa J, Ozelle H,
Martinez J, Atsali E, Vinayak S,
Temmerman M, Figueras F. Routine
third-trimester ultrasound for the
detection of small-for-gestational age
in low-risk pregnancies (ROTTUS
study): randomized controlled
trial. Ultrasound Obstet Gynecol.
2021 Jun;57(6):910-916.

THE JOURNAL OF INFECTIOUS
DISEASES: DECLINE OF
POLIOVIRUS ANTIBODIES
FOLLOWING VACCINATION
Fractional dose (one-fifth of full
intramuscular dose) of inactivated
poliovirus vaccine (fIPV) administered
intradermally is used as an IPV dosesparing strategy. We compared the
rate of decline of poliovirus antibodies
(PVA) in recipients of 2 doses of fIPV or
IPV. A community-based randomized
controlled trial was conducted in
Karachi, Pakistan. Seroprevalence
of poliovirus type 2 antibodies in
170/250 (68%) children after 2 IPV or
fIPV doses at age 10 months in A and
B reached 100% vs 99% (P = .339),
and at 21 months, 86% vs 67% (P =
.004). Between age 10 and 21 months
antibody log2 titers dropped from ≥
10.5 to 6.8 in A and from 9.2 to 3.7 in
B. There was a significant decline in
antibody titers 12 months following
the second IPV dose. The slope of
decline was similar for full IPV and fIPV
recipients. The results provide further
evidence that fIPV is a viable option for
IPV dose-sparing.
Saleem AF, Mach O, Yousafzai MT,
Kazi Z, Baig A, Sajid M, Jeyaseelan
V, Sutter RW, Zaidi AKM. One-Year
Decline of Poliovirus Antibodies
Following Fractional-Dose Inactivated
Poliovirus Vaccine. J Infect Dis.
2021 Apr 8;223(7):1214-1221.
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BMJ: COVID-19 IN SOUTH ASIA
We reviewed the global COVID-19
pandemic profile in South Asia and
other global regions based on publicly
available databases. Although reporting
systems may not have captured the
full magnitude of COVID-19 associated
mortality in phase 1 and 2 of the
pandemic, they do permit reasonable
trend analyses. Over the past year
COVID-19 related deaths remained
much lower in South Asia than in the
US, UK, and Europe, and also lower
than in Brazil, Mexico, and South Africa.
Although the reason for this remains
unclear, it could be partly related to a
relatively younger population with lower
levels of comorbidities that increase
the risks of deaths from COVID-19.
Other intriguing, although unproved,
hypotheses relate to factors such as
innate immunity and previous exposure
to other strains of coronavirus. But with
current half-hearted mitigation measures
and COVID-19 fatigue, this pandemic
could extend its course, exacerbate
disparities, and impact development for
years to come. We need global solidarity
and concerted evidence-informed
efforts to contain this existential threat,
and countries of South Asia need to find
common ground and solutions.
Bhutta ZA, Siddiqi S, Hafeez A, Islam
M, Nundy S, Qadri F, Sultan F. Beyond
the numbers: understanding the
diversity of COVID-19 epidemiology
and response in South Asia.
BMJ. 2021 Jun 25;373:n1544.
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HUMAN RESOURCES FOR HEALTH:
IMPROVING COMMUNITY HEALTH
WORKER PERFORMANCE
Lack of programmatic support and
supervision is one reason for the poor
performance of Pakistan’s Lady Health
Worker (LHW) Programme. This study
assessed a supportive supervision
intervention in two districts of Pakistan
– Badin and Mirpur Khas (MPK) – for
improving LHWs skills for integrated
community case management (iCCM)
of childhood diarrhea and pneumonia.
Lady Health Supervisors received
enhanced supervision training and
provided written feedback to LHWs.
Results showed improvements in LHWs’
skills for iCCM of childhood diarrhea
and pneumonia in both districts. For
example, study arm LHWs performed
better than those in the comparison arm
in classifying diarrhea correctly (68% vs
40% in Badin and 96% vs 83% in MPK).
Supportive supervision including written
feedback and frequent supervisor
contact could improve the performance
of community-based workers in
managing diarrhea and pneumonia
among children.
Aftab W, Piryani S, Rabbani F. Does
supportive supervision intervention
improve community health worker
knowledge and practices for community
management of childhood diarrhea
and pneumonia? Lessons for scaleup from Nigraan and Nigraan Plus
trials in Pakistan. Hum Resour
Health. 2021 Aug 17;19(1):99.

JOURNAL OF THE AMERICAN
ACADEMY OF DERMATOLOGY:
PEMPHIGUS MANAGEMENT
GUIDELINES
The pemphigus group of autoimmune
blistering diseases has a chronic
course leading to significant morbidity
and mortality. In 2020, important
guidelines and recommendations
were published, providing an essential
framework for management. However,
we would like to draw attention to two
important observations/omissions
we believe merit incorporation into
the guidelines. The significance of
pneumocystis pneumonia, which
is a life-threatening yet preventable
complication in patients with pemphigus
and/or those on immunosuppressive
medications, has not been mentioned
in either of the two guidelines. The
use of cyclophosphamide was briefly
mentioned for recalcitrant cases as a
third-line treatment and a drug of last
resort due to potentially severe side
effects. We suggest pulse therapy be
mentioned as a safer option compared
with a daily regimen, especially for
lower- and middle-income countries.
Tabassum S, Rahman A. Pemphigus
management guidelines: A lifesaving perspective. Journal of the
American Academy of Dermatology.
Volume 85, Issue 1, 2021 July 1.

THE LANCET INFECTIOUS
DISEASES: COVID-19-ASSOCIATED
PULMONARY ASPERGILLOSIS

CHEST: MULTIDISCIPLINARY
TEAM MEETINGS AND CANCER
MANAGEMENT

We read with interest the ECMM/
ISHAM consensus criteria for COVID19-associated pulmonary aspergillosis
(CAPA), but noted with concern its
limited applicability to resource-limited
settings. At our institute from July to
December, 2020, 490 tracheal aspirates
were sent for culture, compared with
only two bronchial lavage samples from
COVID-19 patients. Despite having
substantial CAPA burden in our centre,
none of the patients in retrospect could
be categorised into any of the three
grades of proven, probable, or possible,
as suggested by Philipp Koehler and
colleagues. A very restricted disease
categorisation is concerning as it
will lead to under-recognition of this
important complication in patients with
COVID-19, not only for surveillance but
also for their management.

Our team wishes to forward our
comment on a study previously
published in CHEST (December 2020).
For specialists, like us, who are serving
in developing countries, site-specific
multidisciplinary team (MDT) tumor
boards are a life-line for our cancer
patients’ quality health care. It may not
appear too important for the authors
who are working in a system where
100% of cases are discussed in MDT.
Here, in the developing world, we are
struggling hard to develop these sitespecific MDT tumor boards. Because of
this reason, we need to get a very clear
and loud message from the authors that
stage IIIA non-small cell lung cancer
comprises a heterogeneous mixture
of cases and that variations in MDT
opinions are quite natural and likely. In
our opinion, there is a potential danger
that someone can draw a negative
inference from this published study.
This may lead to stoppage of cases
that are brought by physicians for
discussion in tumor boards that are
being conducted on a volunteer basis
in developing countries where all cases
are still not discussed in an MDT before
the commencement of an oncologic
treatment.

Jabeen K, Farooqi J, Irfan M,
Ali SA, Denning DW. Diagnostic
dilemma in COVID-19-associated
pulmonary aspergillosis. Lancet
Infect Dis. 2021 Jun;21(6):767.

Abbasi AN, Qureshi BM, Karim MU.
Impact of Multidisciplinary Team
Meetings and Decision-Making on
Cancer Management in Lower and
Middle Income Countries. Chest.
2021 Feb;159(2):887-888.
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Grants and publications
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